Data as of Dec 18
| +1.35 / +2.03%|
The 14 analysts offering 12-month price forecasts for AbbVie have a median target of 68.50, with a high estimate of 80.00 and a low estimate of 58.00. The median estimate represents a +0.85% increase from the last price of 67.92.
The current consensus among 17 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.